Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-18T18:56:19.729Z Has data issue: false hasContentIssue false

Alcohol use in schizophrenia: prevalence, patterns, correlates and clinical outcomes in Goa, India

Published online by Cambridge University Press:  02 January 2018

Anil Rane*
Affiliation:
Institute of Psychiatry and Human Behaviour, Goa, India
Abhijit Nadkarni
Affiliation:
London School of Hygiene and Tropical Medicine, UK
Jaiprada Kanekar
Affiliation:
Institute of Psychiatry and Human Behaviour, Goa, India
Wenona Fernandes
Affiliation:
Institute of Psychiatry and Human Behaviour, Goa, India
Hirabai A. Borker
Affiliation:
Institute of Psychiatry and Human Behaviour, Goa, India
Yvonne Pereira
Affiliation:
Institute of Psychiatry and Human Behaviour, Goa, India
Rights & Permissions [Opens in a new window]

Abstract

Aims and method

To explore the patterns of alcohol consumption and its impact on clinical outcomes in schizophrenia in low- and middle-income countries. We performed a cross-sectional survey of 315 patients with schizophrenia and calculated the prevalence of alcohol consumption and alcohol use disorder. The patients' sociodemographic profiles and clinical outcomes, including Brief Psychiatric Rating Scale (BPRS) scores, were compared between abstainers and drinkers using the χ2- and t-tests.

Results

The 1-year prevalence of drinking, hazardous drinking and alcohol dependence was 16.8% (95% CI 12.9–21.4), 5.7% (95% CI 3.4–8.9) and 2.5% (95% CI 1.1–4.9), respectively. Male gender, single or post-marital status, higher education and being economically active were significantly associated with alcohol consumption. Alcohol drinkers were significantly more likely to be on combination psychotropics compared with abstainers. The mean total BPRS score was significantly lower in alcohol drinkers compared with abstainers. Drinking alcohol was associated with fewer deficit symptoms.

Clinical implications

Cultural settings have a significant impact on the prevalence of alcohol use disorder in schizophrenia.

Type
Original Papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2012

Schizophrenia with comorbid substance misuse, despite being extensively studied, continues to raise diagnostic queries and poses a management issue across services. The prevalence of comorbid substance use disorder in people with schizophrenia varies widely, from 10% to 70%. Reference Mueser, Yarnold, Levinson, Singh, Bellack and Kee1 The wide range is partly the result of variability in study design, including variability in measurement of schizophrenia and substance use and the type of sample studied (e.g. in-patients v. out-patients, clinical v. community).

Most North American studies estimate that roughly 50% of people diagnosed with schizophrenia also meet criteria for substance use disorders. Reference Regier, Farmer, Rae, Locke, Keith and Judd2-Reference Selzer and Lieberman6 In the Epidemiologic Catchment Area study, 33.7% of people with a lifetime diagnosis of schizophrenia or schizophreniform disorder met criteria for alcohol disorder; and compared with those without schizophrenia, the odds of having an alcohol disorder were over three times higher in people with schizophrenia. Reference Regier, Farmer, Rae, Locke, Keith and Judd2 Similarly, European studies have shown high rates of substance use disorders in people with schizophrenia. Reference Abou-Saleh and Janca7,Reference Schifano and Rassool8 In the UK, the 1-year prevalence of alcohol problems was 32% in psychoses Reference Menezes, Johnson, Thornicroft, Marshall, Prosser and Bebbington9 and 11.7% in first-episode psychoses. Reference Cantwell, Brewin, Glazebrook, Dalkin, Fox and Medley10 In a UK community study, 24% of people with severe mental disorders reported substance misuse, including alcohol misuse (61%), in the previous 12 months. Reference Graham, Maslin, Copello, Birchwood, Mueser and McGovern11 In a study from London, 22.1% of people with schizophrenia had a lifetime history of problem drinking. Reference Duke, Pantelis and Barnes12 In a community sample in Australia, the prevalence of lifetime diagnosis of alcohol use disorder in psychosis was 38% in men and 17% in women, Reference Abou-Saleh and Janca7 and current use of alcohol in a clinic-based sample of schizophrenia was 77.3%. Reference Fowler, Can, Carter and Lewin13 Among low- and middle-income countries (LAMIs), a cross-sectional study from São Paulo, Brazil, reported the prevalence of alcohol misuse or dependence in non-affective psychoses to be 7.3%, much lower than the American and European rates. Reference Menezes and Ratto14 The only Asian data, from a study in Singapore, reported lifetime prevalence rates of 15.8% (‘mild’ use) and 10.3% (‘heavy’ use) in schizophrenia and schizophreniform disorders. Reference Verma, Subramaniam, Chong and Kua15

Comorbidity of substance use in schizophrenia has been associated with adverse outcomes, including higher symptom ratings, poor treatment responses, relapses, frequent hospitalisation, non-adherence, tardive dyskinesia, HIV infection, hepatitis C infection, suicide, and a range of psychosocial difficulties such as violence, victimisation, incarceration, homelessness and family problems. Reference Duke, Pantelis and Barnes12,Reference Swofford, Scheller-Gilkey, Miller, Woolwine and Mance16-Reference Dixon, McNary and Lehman31 Other studies, however, have contradicted these findings or failed to identify robust relationships between the severity of schizophrenic symptoms and substance misuse. Reference Mueser, Yarnold, Levinson, Singh, Bellack and Kee1,Reference Duke, Pantelis and Barnes12,Reference Brunette, Mueser, Xie and Drake32-Reference Sevy, Kay, Opler and van Praag37 Some studies have failed to show the increased frequency of hospital admissions as reported above. Reference Mueser, Yarnold, Levinson, Singh, Bellack and Kee1,Reference Xafenias, Diakogiannis, Iacovides, Fokas and Kaprinis38

The aims of our study were to assess the prevalence of alcohol consumption in a clinical sample of patients with schizophrenia in Goa, India; to investigate the pattern and correlates of alcohol consumption in schizophrenia; and to determine the effect of alcohol consumption on clinical outcomes in schizophrenia.

Method

The setting was the out-patient department of a 190-bed postgraduate university teaching hospital that provides tertiary care mental health services to Goa, one of the smallest states in India. About 100 patients use out-patient services at this hospital every day.

People with schizophrenia who attended out-patient services for at least 12 months and attended follow-up in the 3-month study period were recruited. Diagnosis of schizophrenia was ascertained from case paper records. Patients aged under 18 years or over 65 years were excluded.

Measurement

A structured questionnaire was developed to achieve the study objectives. Data were collected over a 3-month period. Information was gathered from patients, family members and case paper records by two psychiatrists (J.K. and W.F.). The questionnaire was used to collect information in the following domains:

  1. Sociodemographic profile: participants’ age, gender, education, occupation and marital status, who they were living with, and whether they were in receipt of disability benefits.

  2. Alcohol consumption: most preferred drink, preferred place for drinking, age at first drink, morning drinking, drink in past week/month/year/ever, and alcohol consumption in first-degree relatives. Alcohol consumed was assessed as beer, Indian-made foreign liquor (whiskey, vodka, gin, brandy, rum) or country liquor (locally brewed and distilled spirits made from cashew fruit or coconut palm).

  3. Alcohol use disorder: this was measured using the Alcohol Use Disorders Identification Test (AUDIT), a ten-item screening questionnaire developed by the World Health Organization (WHO). Reference Saunders, Aasland, Babor, Fuente and Grant39 The AUDIT has been validated and used in cross-national studies, including in India. Reference Babu and Sengupta40-Reference Gaunekar, Patel, Jacob, Vankar, Mehan, Rane, Howarth and Simpson42 For a previous study, the AUDIT has been translated into Konkani (Goan vernacular) using the translation-back-translation method with two teams of translators, followed by an item-by-item analysis and selection by consensus. Reference Silva, Gaunekar, Patel, Kukalekar and Fernandes43 The WHO-prescribed AUDIT cut-off score of 8 was used to detect hazardous drinking. Participants who drank alcohol but scored below the cut-off score of 8 were coded as casual drinkers. Alcohol dependence was diagnosed using the ICD-10 diagnostic criteria for research. 44

  4. Clinical correlates: duration of psychotic illness, number of in-patient admissions and total in-patient days in the past 12 months, current treatment (typical/atypical/depot antipsychotics and other psychotropic medication), dose of antipsychotic in chlorpromazine equivalents, number of out-patient contacts in the past year, and history of mental illness in first-degree relatives. The Brief Psychiatric Rating Scale (BPRS) was used to assess the psychopathology and severity of illness. Reference Overall and Gorham45 The BPRS was administered to all participants by a senior psychiatrist (A.R.) who was masked to the AUDIT scores. The BPRS has been used for studies on schizophrenia in India. Reference Nagaraj, Pai and Rao46

Analyses

All sociodemographic variables (except age) and clinical outcomes (except the number of in-patient days, chlorpromazine equivalents and BPRS scores) were analysed as categorical variables. Age, number of in-patient days, chlorpromazine equivalents and BPRS scores were analysed as continuous variables. Occupational status was converted into a binary variable by coding unemployed people and homemakers as economically inactive, and full-time or part-time workers as economically active. Marital status was converted into a binary variable as married and single/post-marital (widowed/separated/divorced). Living circumstances were converted to a binary variable by combining living alone with living in supported housing. The duration of illness, number of in-patient admissions and number of out-patient visits were converted to categorical variables. The prevalence of drinking and alcohol use disorder was calculated with 95% confidence intervals. Sociodemographic characteristics and clinical outcomes in the two exposure groups (drinkers, abstainers) were summarised in the form of proportions and means and compared using appropriate statistical tests (χ2-test to compare proportions, t-test to compare means). A P-value of less than 0.05 was considered to be statistically significant. All analyses were performed using STATA 10.0 for Windows.

Ethical considerations

Informed written consent was sought before participation in the study. Participants were free to withdraw from the interview at any point and to choose to not answer questions that they did not feel comfortable with. Participants diagnosed with hazardous drinking had one didactic session where they were given information about the effects of heavy drinking on physical, psychological, social and occupational functioning.

Results

The sample comprised 315 participants. The response rate was 100%, with all eligible participants completing the survey. The sample had a higher proportion of males (57.8%) than females. The mean age of the sample was 41.1 years (s.d. = 11.3). Of the participants, 81.3% had completed secondary education or above and 73.1% of the participants were economically inactive.

The 1-year prevalence of drinking, hazardous drinking and alcohol dependence was 16.8% (95% CI 12.9-21.4), 5.7% (95% CI 3.4-8.9) and 2.5% (95% CI 1.1-4.9) respectively.

The sociodemographic profiles of drinkers and abstainers are compared in Table 1. A significantly higher proportion of males, participants with at least primary education, economically active participants and single/post-marital participants were drinkers.

TABLE 1 Sociodemographic profile of drinkers in schizophrenia

Variable Abstainers
(n = 262)
Drinkers
(n = 53)
P
Gender, % <0.001Footnote *
    Male 74.7 25.3
    Female 94.7 5.3
Mean age, years (s.d.) 40.8 (11.0) 42.6 (12.7) 0.27
Living arrangements, % 0.37
    Living with family 83.6 16.4
    Living alone or in supported housing 75.0 25.0
Marital status, % 0.02Footnote *
    Married 87.4 12.6
    Single or post-marital 77.9 22.1
Education, % 0.04Footnote *
    None 95.8 4.2
    Completed primary education 68.6 31.4
    Completed secondary education 84.8 15.2
    Completed higher secondary education or above 82.4 17.7
Occupation, % 0.003Footnote *
    Economically active 72.6 27.4
    Economically inactive 87.0 13.0
Recipient of disability benefits, % 0.26
    No 84.1 15.9
    Yes 77.3 22.7

* Value significant at <0.05.

The most preferred drink was beer (36.2%), followed by Indian-made foreign liquor (25.5%). Of the current drinkers, 63.3% drank in bars and 14.3% drank at home; 63.3% had started drinking before the age of 25 years; and 11.3% reported morning drinking. Hazardous drinkers exclusively drank spirits (66.7%) and country liquor (33.3%), while casual drinkers were more likely to drink beer (53.1%); 87.5% of hazardous drinkers drank in bars, but only 51.5% of casual drinkers drank in bars. Compared with casual drinkers (5.7%), a higher proportion of hazardous drinkers (22.2%) reported morning drinking.

Compared with abstainers, higher proportions of drinkers had a longer duration of schizophrenic illness, mental illness in first-degree relatives, more in-patient stays on a mental health ward, and longer mean in-patient stays. A higher proportion of abstainers, however, had more than 12 out-patient visits in the past year compared with drinkers. Drinkers were more likely to be on typical antipsychotics or depot antipsychotics than abstainers; but abstainers were on higher mean doses of antipsychotics in chlorpromazine equivalents compared with drinkers. None of these findings are statistically significant at P<0.05. The only statistically significant difference was that a higher proportion of drinkers were on combination psychotropics compared with abstainers.

A higher proportion of hazardous drinkers had an illness duration of more than 10 years compared with casual drinkers (77.8% v. 60%, P = 0.19). Hazardous drinkers were more likely than casual drinkers to have two or more admissions in the past year (22.2% v. 2.9%, P = 0.06) and a longer mean in-patient stay (24.1 days v. 7.8 days, P = 0.12). Hazardous drinkers were more often prescribed a combination of psychotropics compared with casual drinkers (27.8% v. 22.9%, P = 0.69) and needed higher mean chlorpromazine equivalent doses (305.9 mg v. 296.5 mg, P = 0.89). Hazardous drinkers had higher BPRS scores compared with casual drinkers (10.9 v. 7.2, P = 0.06). None of these differences were clinically significant.

The BPRS scores (individual items and total) of drinkers and abstainers are compared in Table 2. The mean total BPRS score was significantly lower in drinkers compared with abstainers. The mean scores on the following items of the scale were significantly lower in drinkers compared with abstainers: somatic concerns, unusual thought content, hallucinations, conceptual disorganisation, blunted affect, emotional withdrawal, motor retardation, tension and uncooperativeness.

TABLE 2 Brief Psychiatric Rating Scale (BPRS) scores in schizophrenia

BPRS score, mean (s.d.)
BPRS item Abstainers Drinkers P
Disorientation 0.88 (1.35) 0.73 (1.14) 0.45
Somatic concerns 1.14 (1.32) 0.71 (1.13) 0.03Footnote *
Anxiety 1.76 (1.18) 1.43 (1.16) 0.06
Guilt 0.12 (0.54) 0.03 (0.27) 0.25
Depression 0.03 (0.24) 0 (0) 0.37
Grandiosity 0.14 (0.55) 0.13 (0.62) 0.91
Suspiciousness 0.41 (0.9) 0.35 (0.87) 0.69
Hostility 0.01 (0.12) 0 (0) 0.36
Unusual thought content 0.72 (1.22) 0.33 (0.8) 0.03Footnote *
Hallucinations 0.91 (1.27) 0.49 (1.03) 0.02Footnote *
Conceptual disorganisation 1.75 (1.79) 0.98 (1.42) 0.003Footnote *
Blunted affect 1.67 (1.94) 0.96 (1.6) 0.01Footnote *
Emotional withdrawal 0.83 (1.1) 0.52 (0.91) 0.05Footnote *
Motor retardation 0.25 (0.75) 0.01 (0.13) 0.02Footnote *
Tension 1.35 (1.86) 0.6 (1.3) 0.005Footnote *
Uncooperativeness 1.36 (1.13) 0.98 (1.1) 0.03Footnote *
Excitement 0.25 (0.8) 0.24 (0.7) 0.9
Mannerisms/posturing 0 (0) 0 (0)
Total 13.64 (10.28) 8.45 (6.92) <0.001Footnote *

* Value significant at <0.05.

Discussion

This cross-sectional exploratory study assessed the prevalence and correlates of alcohol drinking and its impact on clinical outcome in patients with schizophrenia. The 12-month prevalence rates of alcohol consumption, hazardous drinking and alcohol dependence were 16.8%, 5.7% and 2.5% respectively. This is lower than the prevalence of hazardous drinking in a primary care setting in Goa (8.2%) Reference D'Costa, Nazareth, Naik, Vaidya, Levy and Patel47 and in people with psychotic disorder from São Paulo, Brazil (7.3%). Reference Menezes and Ratto14 Furthermore, the rates are much lower than the rates of alcohol use disorder in the USA (33.7%) Reference Regier, Farmer, Rae, Locke, Keith and Judd2 and the UK (32%). Reference Menezes, Johnson, Thornicroft, Marshall, Prosser and Bebbington9 This further emphasises that the cultural and regional differences in alcohol use patterns that are prevalent in the community extend to clinical samples of people with severe mental illness. Researchers have argued that the prevalence of substance misuse in severe mental illness is associated with the use and availability of that particular substance in the general population; Reference Menezes, Johnson, Thornicroft, Marshall, Prosser and Bebbington9 the low prevalence of alcohol use disorder in our sample is probably a reflection of the low prevalence of alcohol use disorder in the general population in India (current alcohol use 6%, Reference Ray, Mondal, Gupta, Chatterjee and Bajaj48 alcohol dependence 0.7% Reference Reddy and Chandrashekar49 ).

In our study, males were more likely than females to use alcohol, a finding that has been demonstrated in the general population in Goa Reference D'Costa, Nazareth, Naik, Vaidya, Levy and Patel47 and in people with mental health problems globally. Reference Margolese, Negrete, Tempier and Gill23,Reference Mueser, Yarnold, Rosenberg, Swett, Miles and Hill50 Being unmarried or post-marital was significantly associated with drinking alcohol in our study. This is consistent with similar findings in other community Reference Hall, Teesson, Lynskey and Degenhardt51 and clinic Reference Fowler, Can, Carter and Lewin13 studies. This probably points to the critical role of family and social pressures in substance misuse behaviour. Ongoing family support is known to be associated with substantial reductions in adverse outcomes of substance use. Reference Fischer, McSweeney, Pyne, Williams, Naylor and Blow52 Contrary to earlier reports from high-income countries, Reference Mueser, Yarnold, Levinson, Singh, Bellack and Kee1,Reference Drake and Wallach21,Reference Hall, Teesson, Lynskey and Degenhardt51 in our study people who were economically active and had received formal education were more likely to be drinkers compared with those who were economically inactive and illiterate. A similar association between employment and drinking has been shown in men attending private primary care clinics in Goa, Reference D'Costa, Nazareth, Naik, Vaidya, Levy and Patel47 where men who consumed any alcohol were more likely than abstainers to be employed. In another in-patient-based course and outcome study of substance misuse comorbidity in schizophrenia from India, it was reported that people misusing substances were more likely to be employed compared with those not using any substance. Reference Aich, Sinha, Khess and Singh53 A possible explanation for this could be that in the absence of social security and pension schemes for chronically ill people in India, unlike in many high-income countries, only people with financial resources may be able to procure alcohol in India.

We did not find any significant association between drinking and clinical outcomes in schizophrenia, such as duration of illness, medication dosage or mental health service use. This may possibly be because the drinkers in our study were using alcohol at a less abusive level than the drinkers reported in other studies, especially from the USA. Some of our findings are supported by an Australian study that, despite having a high prevalence of substance misuse, could not demonstrate that substance misuse adversely affects the course of schizophrenia in terms of hospital admissions, suicide attempts or doses of antipsychotic drugs. Reference Fowler, Can, Carter and Lewin13 Nevertheless, there is published evidence that heavy alcohol use is associated with adverse outcomes. In a study of community-dwelling people with chronic mental illness in Massachusetts, USA, Reference Drake and Wallach21 people who misused substances were less able to manage their lives in the community compared with those who were not misusing any substance in terms of maintaining regular meals, adequate finances, stable housing and regular activities. They also showed greater hostility, suicidality and speech disorganisation, had poorer medication adherence and had increased rehospitalisation. A major finding in our study is that drinkers had significantly lower mean BPRS scores compared with non-drinkers. They had significantly low scores on all items that are considered negative symptoms of schizophrenia, namely blunted affect emotional withdrawal and motor retardation. There were also significantly low scores on the tension, uncooperativeness, somatic concerns, conceptual disorganisation and hallucination BPRS items. This may be at odds with earlier reports, Reference Swofford, Scheller-Gilkey, Miller, Woolwine and Mance16,Reference Inderbitzin, Scheller-Gilkey and Lewine17 but some studies have shown low BPRS scores in people with dual diagnosis compared with people with a single diagnosis. Reference Blow, Barry, Bootsmiller, Copeland, McCormick and Visnic54 There is evidence for different patient profiles in dual diagnosis. Some patients have higher symptom levels and poor social skills, but other patients have lower symptom levels, especially negative symptoms, and better social skills compared with people with schizophrenia who do not misuse substances. Reference Arndt, Tyrrell, Flaum and Andreasen55-Reference Salyers and Mueser57 Predominance of negative symptoms in people with schizophrenia who do not misuse substances has been reported from studies in India Reference Aich, Sinha, Khess and Singh53 and other LAMI settings. Reference Menezes and Ratto14 There are also supporters of the self-medication theory, which suggests that by misusing psychoactive substances, people with schizophrenia relieve their negative symptoms. Reference Potvin, Sepehry and Stip58

From our study, the profile of a person with schizophrenia who drinks alcohol is a single or post-marital male who is economically active, has received formal education, has a lower symptom burden, especially of negative symptoms, and has adverse illness outcomes compared with patients who abstain from drinking. In our opinion, the lower symptom scores on the BPRS and the absence of adverse outcomes in drinkers is not an outcome of drinking behaviour. Cultural context in the use of alcohol may have a role to play. In high-income countries, deinstitutionalisation is considered to have put patients at risk of misusing substances. Reference Menezes, Johnson, Thornicroft, Marshall, Prosser and Bebbington9 In the Indian setting, patients are more often under supervision of their families. Although alcohol is freely available, especially in Goa, drinking is not as ubiquitous in India as in high-income countries. Only patients with fewer deficit symptoms and with financial resources would be able to procure alcohol for consumption. It has been suggested that patients with more severe negative symptoms and premorbid functioning characterised by social isolation may lack the exposure to illicit substances or the social skills necessary to obtain them regularly to develop a drug use disorder. Reference Cohen and Klein59 We can effectively conclude, therefore, that drinking alcohol is a result of better clinical outcomes and consequent better social functioning rather than the other way round.

Although people with schizophrenia who drank alcohol fared better symptomatically than abstainers, the subanalysis of drinkers showed a trend for worse outcomes with rising levels of drinking. Hazardous drinkers in our study had a longer illness duration, had more and longer in-patient admissions, needed more and higher doses of medication, and had higher BPRS scores. The drinking profile also worsens in hazardous drinkers, with hazardous drinkers exclusively drinking spirits and country liquor with a high alcohol content. Hazardous drinking is also more likely to occur in bars, and there are higher reports of morning drinking. These findings are in keeping with earlier studies on hazardous drinking. Reference Gaunekar, Patel and Rane41

The main limitations of our study relate to the cross-sectional design, which does not allow us to determine the direction of causality of the detected associations. Furthermore, our sample is relatively small, in keeping with the exploratory nature of our study. Finally, the lack of a validated vernacular version of an instrument such as the Structured Clinical Interview for DSM Disorders means that we had to rely on clinical diagnosis to identify people with schizophrenia. Our findings do show certain trends that are different from those seen in studies conducted in high-income countries. This strengthens the case for conducting a more comprehensive study, with a larger sample size, exploring the long-term course and outcomes of people with schizophrenia and comorbid alcohol use in India and other LAMI countries. As our sample was derived from a tertiary care mental health service, there is a potential for selection bias leading to overestimation of prevalence rates, as is common in specialist clinic-based studies. Since Goa is a small state, with the tertiary care hospital being easily accessible to the whole population, however, it is possible that our findings will be a true reflection of alcohol use in a community sample of people with psychotic disorders. The reliability of responses given in interviews to sensitive questions about one's alcohol use is uncertain. The data in our study were built on standardised assessment instruments such as the AUDIT and BPRS, which have established reliability allowing direct comparisons with other studies. Finally, because of the stigma attached to mental health problems, there is the possibility of underreporting of use of mental health services by the participants. There could also have been underreporting of alcohol consumption, especially since the data collectors were also involved in the clinical care of some of the participants. Alternative methods for independent verification of self-reports of such sensitive behaviours would not have been cost-effective, feasible or ethical, however. The alternative of using a self-administered questionnaire would have come with the attendant disadvantage of poor response rates.

Footnotes

Declaration of interest

None.

References

1 Mueser, KT, Yarnold, PR, Levinson, DF, Singh, H, Bellack, AS, Kee, K, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990; 16: 3156.CrossRefGoogle ScholarPubMed
2 Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ, Judd, LL, et al. Comorbidity of mental disorders with alcohol and other drug abuses. J Am Med Assoc 1990; 264: 2511–8.Google Scholar
3 Westermeyer, J. Schizophrenia and substance abuse. In Review of Psychiatry, Vol. 11) (eds Tasman, A, Riba, MR): 379401. American Psychiatric Press, 1992.Google Scholar
4 Drake, RE, Osher, FC, Noordsy, DL, Hurlbut, SC, Teague, GB, Beaudett, MS. Diagnosis of alcohol use disorders in schizophrenia, Schizophr Bull 1990; 16: 5767.Google Scholar
5 El-Guebaly, N, Hodgkins, DC. Schizophrenia and substance abuse: prevalence issues. Can J Psychiatry 1992; 37: 704–10.CrossRefGoogle ScholarPubMed
6 Selzer, JA, Lieberman, JA. Schizophrenia and substance abuse. Psychiatr Clin North Am 1993; 16: 401–12.Google Scholar
7 Abou-Saleh, MT, Janca, A. The epidemiology of substance misuse and comorbid psychiatric disorders. Acta Neuropsychiatr 2004; 16: 38.Google Scholar
8 Schifano, F. European dimensions of dual diagnosis. In Dual Diagnosis: Substance Misuse and Psychiatric Disorders (ed. Rassool, GH): 5865. Blackwell Science, 2002.Google Scholar
9 Menezes, PR, Johnson, S, Thornicroft, G, Marshall, J, Prosser, D, Bebbington, P, et al. Drug and alcohol problems among individuals with severe mental illnesses in south London. Br J Psychiatry 1996; 168: 612–9.Google Scholar
10 Cantwell, R, Brewin, J, Glazebrook, C, Dalkin, T, Fox, R, Medley, I, et al. Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 1999; 174: 150–3.CrossRefGoogle ScholarPubMed
11 Graham, HL, Maslin, J, Copello, A, Birchwood, M, Mueser, K, McGovern, D, et al. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 448–55.Google Scholar
12 Duke, PJ, Pantelis, C, Barnes, TR. South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 1994; 164: 630–6.Google Scholar
13 Fowler, IL, Can, VJ, Carter, NT, Lewin, TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443–55.CrossRefGoogle ScholarPubMed
14 Menezes, PR, Ratto, LR. Prevalence of substance misuse among individuals with severe mental illness in São Paulo. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 212–7Google Scholar
15 Verma, SK, Subramaniam, M, Chong, S, Kua, EH. Substance abuse in schizophrenia: a Singapore perspective. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 326–8.Google Scholar
16 Swofford, CD, Scheller-Gilkey, G, Miller, AH, Woolwine, B, Mance, R. Double jeopardy: schizophrenia and substance use. Am J Drug Alcohol Abuse 2000; 26: 343–53.Google Scholar
17 Inderbitzin, LB, Scheller-Gilkey, G, Lewine, RJ. A double-blind dosage reduction trial of fluphenazine decanoate in chronic, unstable schizophrenic patients. Am J Psychiatry 1994; 151: 1753–9.Google Scholar
18 Bowers, MB, Mazure, CM, Nelson, CJ, Jatlow, PI. Psychotogenic drug use and neuroleptic response. Schizophr Bull 1990; 16: 81–5.Google Scholar
19 Swofford, CD, Kasckow, JW, Scheller-Gilkey, G, Inderbitzin, LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996; 20: 145–51.Google Scholar
20 Haywood, TW, Kravitz, HM, Grossman, LS, Cavanaugh, JL Jr, Davis, JM, Lewis, DA. Predicting the revolving door phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 1995; 152: 856–61.Google Scholar
21 Drake, RE, Wallach, MA. Substance abuse among the chronic mentally ill. Hosp Community Psychiatry 1989; 40: 1041–6.Google ScholarPubMed
22 Drake, RE, Osher, FC, Wallach, MA. Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 1989; 177: 408–13.Google Scholar
23 Margolese, HC, Negrete, JC, Tempier, R, Gill, K. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use. Schizophr Res 2006; 83: 6575.CrossRefGoogle ScholarPubMed
24 Cournos, F, Empfield, M, Horwath, E, McKinnon, K, Meyer, I, Schrage, H, et al. HIV prevalence among patients admitted to two psychiatric hospitals. Am J Psychiatry 1991; 148: 1225–9.Google ScholarPubMed
25 Rosenberg, SD, Goodman, LA, Osher, FC, Swartz, MS, Essock, SM, Butterfield, MI, et al. Prevalence of HIV, hepatitis B and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91: 31–7.Google Scholar
26 Bartels, SJ, Drake, RE, McHugo, G. Alcohol abuse, depression, and suicidal behavior in schizophrenia. Am J Psychiatry 1992; 149: 394–5.Google ScholarPubMed
27 Swartz, MS, Swanson, JW, Hiday, V, Borum, R, Wagner, HR, Burns, BJ, et al. Violence and severe mental illness: the effects of substance abuse and non-adherence to medication. Am J Psychiatry 1998; 15: 226–31.Google Scholar
28 Goodman, LA, Salyers, MP, Mueser, KT, Rosenberg, SD, Swartz, M, Essock, SM, et al. Recent victimization in women and men with severe mental illness: prevalence and correlates. J Trauma Stress 2001; 14: 615–32.Google Scholar
29 Abram, K, Teplin, L. Co-occurring disorders among mentally ill jail detainees: implications for public policy. Am J Psychologist 1991; 46: 1036–44.Google Scholar
30 Caton, C, Shrout, P, Eagle, P, Opler, LA, Felix, A, Dominguez, B. Risk factors for homelessness among schizophrenic men: a case–control study. Am J Public Health 1994; 84: 265–70.CrossRefGoogle ScholarPubMed
31 Dixon, L, McNary, S, Lehman, A. Substance abuse and family relationships of persons with severe mental illness. Am J Psychiatry 1995; 152: 456–8.Google ScholarPubMed
32 Brunette, MF, Mueser, KT, Xie, H, Drake, RE. Relationships between symptoms of schizophrenia and substance abuse. J Nerv Ment Dis 1997; 185: 1320.Google Scholar
33 Alterman, AI, Ayre, FR, Williford, WO. Diagnostic validation of conjoint schizophrenia and alcoholism. J Clin Psychiatry 1984; 5: 300–3.Google Scholar
34 Cuffel, BJ, Heithhoff, KA, Lawson, W. Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry 1993; 44: 247–51.Google Scholar
35 Serper, MR, Alpert, M, Richardson, NA, Dickson, S, Allen, MH, Werner, A. Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry 1995; 152: 1464–9.Google Scholar
36 Rosenthal, RN, Hellerstein, KJ, Miner, CR. Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Compr Psychiatry 1994; 35: 91–8.Google Scholar
37 Sevy, S, Kay, SR, Opler, LA, van Praag, HM. Significance of cocaine history in schizophrenia. J Nerv Ment Dis 1990; 178: 642–8.Google Scholar
38 Xafenias, A, Diakogiannis, I, Iacovides, A, Fokas, K, Kaprinis, G. Factors affecting hospital length of stay: is substance use disorder one of them? A study in a Greek public psychiatric hospital. Am J Addict 2008; 17: 447–51.Google Scholar
39 Saunders, JB, Aasland, OG, Babor, TF, Fuente, JR, Grant, M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption – II. Addiction 1993; 88: 791804.Google Scholar
40 Babu, RS, Sengupta, SN. A study of problem drinkers in a general hospital. Indian J Psychiatry 1997; 39: 13–7.Google Scholar
41 Gaunekar, G, Patel, V, Rane, A. The impact and patterns of hazardous drinking amongst male industrial workers in Goa, India. Soc Psychiatry Psychiatr Epidemiol 2005; 40: 267–75.Google Scholar
42 Gaunekar, G, Patel, V, Jacob, KS, Vankar, G, Mehan, D, Rane, A, et al. Drinking patterns of hazardous drinkers: a multicenter study in India. In Moonshine Markets: Issues in Unrecorded Alcohol Beverage Production and Consumption (eds Howarth, A, Simpson, R): 122–41. Brunner-Routledge, 2004.Google Scholar
43 Silva, MC, Gaunekar, G, Patel, V, Kukalekar, DS, Fernandes, J. The prevalence and correlates of hazardous drinking in industrial workers: a study from Goa, India. Alcohol Alcohol 2003; 38: 7983.Google Scholar
44 World Health Organization. ICD-10 Classification of Mental and Behavioural Disorders, Diagnostic Criteria for Research. WHO, 1993.Google Scholar
45 Overall, JE, Gorham, DR. The brief psychiatric rating scale. Psychol Rep 1962; 10: 799812.Google Scholar
46 Nagaraj, AK, Pai, NB, Rao, S. A comparative study of sexual dysfunction involving risperidone, quetiapine and olanzapine. Indian J Psychiatry 2009; 51: 265–71.Google Scholar
47 D'Costa, G, Nazareth, I, Naik, D, Vaidya, R, Levy, G, Patel, V, et al. Harmful alcohol use in Goa, India, and its associations with violence: a study in primary care. Alcohol Alcohol 2007; 42: 131–7.Google Scholar
48 Ray, R, Mondal, AB, Gupta, K, Chatterjee, A, Bajaj, P. The Extent, Pattern and Trends of Drug Abuse in India: National Survey. United Nations Office on Drugs and Crimes and Ministry of Social Justice and Empowerment, Government of India, 2004.Google Scholar
49 Reddy, MV, Chandrashekar, CR. Prevalence of mental and behavioral disorders in India: a meta-analysis. Indian J Psychiatry 1998; 40: 149–57.Google Scholar
50 Mueser, KT, Yarnold, PR, Rosenberg, ST, Swett, C Jr, Miles, KM, Hill, D. Substance use disorder in hospitalised severely mentally ill psychiatric patients: prevalence, correlates and subgroups. Schizophr Bull 2000; 26: 179–92.Google Scholar
51 Hall, W, Teesson, M, Lynskey, M, Degenhardt, L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from National Survey of Mental Health and Well Being. Addiction 1999; 94: 1541–50.Google Scholar
52 Fischer, EP, McSweeney, JC, Pyne, JM, Williams, DK, Naylor, AJ, Blow, FC, et al. Influence of family involvement and substance use on sustained utilisation of services for schizophrenia. Psychiatr Serv 2008; 59: 902–8.Google Scholar
53 Aich, TK, Sinha, VK, Khess, C, Singh, S. Substance abuse co-morbidity in schizophrenia: an in-patient study of course and outcome. Indian J Psychiatry 2005; 47: 33–8.Google Scholar
54 Blow, FC, Barry, KL, Bootsmiller, BJ, Copeland, LA, McCormick, R, Visnic, S. Longitudinal assessment of inpatient use and functioning of seriously mentally ill veterans with and without co-occurring substance use disorders. J Psychiatr Res 2008; 32: 311–9.Google Scholar
55 Arndt, S, Tyrrell, G, Flaum, M, Andreasen, NC Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 1992; 22: 379–88.Google Scholar
56 Dixon, L, Haas, G, Weiden, PJ, Sweeney, J, Frances, AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1994; 148: 224–30.Google Scholar
57 Salyers, MP, Mueser, KT. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 2001; 48: 109–23.Google Scholar
58 Potvin, S, Sepehry, A, Stip, E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med 2006; 36: 431–40.Google Scholar
59 Cohen, M, Klein, DF. Drug abuse in a young psychiatric population. Am J Orthopsychiatry 1970; 40: 448–55.CrossRefGoogle Scholar
Figure 0

TABLE 1 Sociodemographic profile of drinkers in schizophrenia

Figure 1

TABLE 2 Brief Psychiatric Rating Scale (BPRS) scores in schizophrenia

Submit a response

eLetters

No eLetters have been published for this article.